Tandem Diabetes Care, Inc. (TNDM)
$22.22-0.45%Close
BUYRECOVERY · day 32
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1.5B
- Avg volume
- 2.3M
- Beta
- 1.54
- P/E (TTM)
- -23.93
- Short % float
- 17.87%
- Days to cover
- 6.6
- SI change
- -14.3%
- 1W
- -0.18%
- 1M
- +29.79%
- 3M
- +48.43%
- YTD
- +3.11%
- vs SPY 1W
- +1.01%
- vs SPY 1M
- +26.47%
- vs SPY 3M
- +46.04%
- vs SPY YTD
- -8.64%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CTMXBUYCytomX Therapeutics, Inc.RECOVERYQ 8$3.29+0.30%
- LCTXSELLLineage Cell Therapeutics, Inc.RECOVERYQ 11$1.09+0.93%
- STOKBUYStoke Therapeutics, Inc.RECOVERYQ 13$32.32+0.09%
- TNGXSELLTango Therapeutics, Inc.CRISISQ 24$24.51+2.64%
- ISPCSELLiSpecimen Inc.CRISISQ -26$1.57-7.10%
- SGHTBUYSight Sciences, Inc.RECOVERYQ -13$8.38+1.45%
- SCLXSELLScilex Holding CompanyCRISISQ -22$5.66-1.22%
- BRTXSELLBioRestorative Therapies, Inc.CRISISQ -14$0.21-4.55%
- MSPRSELLMSP Recovery, Inc.RECOVERYQ -29$0.00
- RNXTBUYRenovoRx, Inc.RECOVERYQ -2$1.25-5.30%
- AEMDSELLAethlon Medical, Inc.CRISISQ -9$2.64-3.30%
- AMRNBUYAmarin Corporation plcRECOVERYQ 2$13.84-1.77%
Industry peers
FMP comparable companies · ranked by market cap
- TNGXSELLTango Therapeutics, Inc.$3.9BCRISISQ 24$23.88+2.64%
- NRIXBUYNurix Therapeutics, Inc.$2.8BBULLQ 13$26.72-1.68%
- KODSELLKodiak Sciences Inc.$2.4BCRISISQ 37$38.33-2.90%
- URGNBUYUroGen Pharma Ltd.$2.3BBULLQ 23$46.86-1.49%
- SEPNBUYSepterna Inc$1.8BCRISISQ 29$40.00+1.30%
- FTRESELLFortrea Holdings Inc.$1.7BBEARQ -4$18.39-0.44%
- IARTSELLIntegra LifeSciences Holdings Corporation$1.3BCRISISQ 10$16.74-0.30%
- INMDSELLInMode Ltd.$866MBULLQ 16$15.06+0.27%
- PHATSELLPhathom Pharmaceuticals, Inc.$718MCRISISQ 6$8.87-2.37%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 0
- GROWTH
- 34
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-27.6%
REV YoY-
ROE-46.0%
EPS YoY-
ROA-5.5%
GROSS56
OP-4
NET-6
[VALUATION]
P/E TTM-23.93
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B11.66
P/FCF-
EV/EBITDA-72.55
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E566.96
ALTMAN Z-
CURR RATIO3.18
ND/EBITDA-
BETA1.54
